HB93
|
Wachsmann |
Alpha-gal syndrome; Board of Health shall adopt regulations to include on reportable disease list. |
Summary:
Alpha-gal syndrome; Board of Health; reportable disease list.
Directs the Board of Health to adopt regulations to include alpha-gal syndrome on the list of diseases that shall be required to be reported in accordance with the Code of Virginia. The bill has a delayed effective date of July 1, 2025.
|
Fiscal Impact
|
Last Five Actions:
2/9/2024 - VOTE: Block Vote Passage (96-Y 0-N) 3/25/2024 - Enrolled 3/25/2024 - Bill text as passed House and Senate (HB93ER) 3/26/2024 - Signed by Speaker 3/27/2024 - Enrolled Bill communicated to Governor on March 27, 2024
|
Senate Committee Actions:
2/29/2024 - Reported from Finance and Appropriations (14-Y 0-N) 3/4/2024 - Constitutional reading dispensed (40-Y 0-N) 3/5/2024 - Read third time 3/5/2024 - Passed Senate (40-Y 0-N) 3/25/2024 - Signed by President
|
Health and Human Resources Subcommittee
|
Subcommittee recommends reporting (8-Y 0-N)
|
HB169
|
Keys-Gamarra |
Maternal Health Data and Quality Measures, Task Force on; State Health Commissioner to reestablish. |
Summary:
Task Force on Maternal Health Data and Quality Measures; report.
Directs the State Health Commissioner to reestablish the Task Force on Maternal Health Data and Quality Measures for the purpose of evaluating maternal health data collection processes to guide policies in the Commonwealth to improve maternal care, quality, and outcomes for all birthing people in the Commonwealth. The bill directs the Task Force to report its findings and conclusions to the Governor and General Assembly by December 1 of each year regarding its activities. This bill reestablishes the Task Force on Maternal Health Data and Quality Measures that concluded on December 1, 2023. This bill was incorporated into HB 781.
|
Fiscal Impact
|
Last Five Actions:
1/2/2024 - Referred to Committee on Health and Human Services 1/17/2024 - Assigned sub: Health 1/23/2024 - Subcommittee recommends incorporating (HB781-Herring) 1/23/2024 - Impact statement from DPB (HB169) 1/25/2024 - Incorporated by Health and Human Services (HB781-Herring)
|
Related Bills:
HB286 (McQuinn) - Maternal Health Data and Quality Measures, Task Force on.
|
Health
|
Subcommittee recommends incorporating (HB781-Herring)
|
HB188
|
Hope |
Advance Health Care Planning Registry; amendment of regulations. |
Summary:
Advance Health Care Planning Registry; amendment of regulations.
Amends the list of documents that may be submitted to the Advance Health Care Directive Registry to include any other document that supports advance health care planning. The bill also changes the name of the Advance Health Care Directive Registry to the Advance Health Care Planning Registry. The bill directs the Department of Health to amend certain Advance Health Care Planning Registry regulations. This bill is identical to SB 154.
|
Fiscal Impact
|
Last Five Actions:
2/27/2024 - Enrolled 2/27/2024 - Bill text as passed House and Senate (HB188ER) 2/27/2024 - Impact statement from DPB (HB188ER) 2/27/2024 - Signed by Speaker 3/11/2024 - Enrolled Bill communicated to Governor on March 11, 2024
|
Senate Committee Actions:
2/19/2024 - Reading of substitute waived 2/19/2024 - Committee substitute agreed to 24107757D-S1 2/19/2024 - Engrossed by Senate - committee substitute HB188S1 2/19/2024 - Passed Senate with substitute 24107757D-S1 (39-Y 0-N) 3/1/2024 - Signed by President
|
Related Bills:
SB154 (Head) - Advance Health Care Planning Registry; amendment of regulations.
|
Health
|
Subcommittee recommends reporting (8-Y 0-N)
|
HB252
|
Cole |
Sickle cell disease; statewide registry created, collection of disease case information, report. |
Summary:
Sickle cell disease; statewide registry; collectionof sickle cell disease case information; penalties; notification;annual report.
Creates a statewide registry of sickle cell diseasepatients to be maintained by the State Health Commissioner. The billestablishes: (i) standards and selection criteria for the collectionof sickle cell disease information; (ii) penalties for unauthorizeduse of data from such registry; and (iii) notice requirements forpatients whose personal identifying information has been submittedto such registry. The bill allows patients diagnosed with sicklecell disease to self-report information to the sickle cell diseaseregistry. Under the bill, a patient has the right to opt out of havinghis information reported to the statewide sickle cell disease registry.The bill also directs the Commissioner to submit an annual reportof the information obtained from the sickle cell disease registryto the Governor and the General Assembly by November 1 of each year.
|
Fiscal Impact
|
Last Five Actions:
3/25/2024 - Enrolled 3/25/2024 - Bill text as passed House and Senate (HB252ER) 3/26/2024 - Signed by Speaker 3/27/2024 - Impact statement from DPB (HB252ER) 3/27/2024 - Enrolled Bill communicated to Governor on March 27, 2024
|
Senate Committee Actions:
3/7/2024 - Senate requested conference committee 3/7/2024 - Conferees appointed by Senate 3/7/2024 - Senators: Favola, Bagby, Head 3/8/2024 - Conference report agreed to by Senate (40-Y 0-N) 3/25/2024 - Signed by President
|
Health and Human Resources Subcommittee
|
Subcommittee recommends reporting (8-Y 0-N)
|
HB255
|
Mundon King |
Adult wellness screening; sickle cell disease or sickle cell trait. |
Summary:
Adult wellness screening; sickle cell disease or sickle cell trait.
Provides that every adult resident of the Commonwealth may be offered screening tests for sickle cell disease or the sickle cell trait and requires that the health care professional in charge of an adult's annual health examination provide education and appropriate counseling regarding the results of any such test that is performed.
|
Fiscal Impact
|
Last Five Actions:
2/29/2024 - Enrolled 2/29/2024 - Bill text as passed House and Senate (HB255ER) 2/29/2024 - Impact statement from DPB (HB255ER) 2/29/2024 - Signed by Speaker 3/11/2024 - Enrolled Bill communicated to Governor on March 11, 2024
|
Senate Committee Actions:
2/22/2024 - Reported from Education and Health (15-Y 0-N) 2/23/2024 - Constitutional reading dispensed (38-Y 0-N) 2/26/2024 - Read third time 2/26/2024 - Passed Senate (40-Y 0-N) 3/3/2024 - Signed by President
|
Health
|
Subcommittee recommends reporting with substitute (8-Y 0-N); Subcommittee recommends referring to Committee on Appropriations
|
HB257
|
Mundon King |
Sickle cell anemia; prescription of opioids for pain management. |
Summary:
Prescription of opioids; sickle cell anemia.Exempts prescribers from certain requirements of the PrescriptionMonitoring Program related to prescribing opioids if the opioid isprescribed to a patient for pain management related to sickle cellanemia.
|
Fiscal Impact
|
Last Five Actions:
3/7/2024 - Enrolled 3/7/2024 - Bill text as passed House and Senate (HB257ER) 3/7/2024 - Impact statement from DPB (HB257ER) 3/7/2024 - Signed by Speaker 3/11/2024 - Enrolled Bill communicated to Governor on March 11, 2024
|
Senate Committee Actions:
2/29/2024 - Reported from Education and Health (13-Y 2-N) 3/1/2024 - Constitutional reading dispensed (40-Y 0-N) 3/4/2024 - Read third time 3/4/2024 - Passed Senate (39-Y 0-N) 3/8/2024 - Signed by President
|
Health
|
Subcommittee recommends reporting (6-Y 2-N)
|
HB353
|
Hope |
Hospitals; emergency departments to have at least one licensed physician on duty at all times. |
Summary:
Hospitals; emergency departments; licensed physicians.
Requires any hospital with an emergency department to have at least one licensed physician on duty and physically present at all times. Current law requires such hospitals to have a licensed physician on call, though not necessarily physically present on the premises, at all times. The bill has a delayed effective date of July 1, 2025 and is identical to SB 392.
|
Fiscal Impact
|
Last Five Actions:
3/25/2024 - Enrolled 3/25/2024 - Bill text as passed House and Senate (HB353ER) 3/26/2024 - Signed by Speaker 3/27/2024 - Impact statement from DPB (HB353ER) 3/27/2024 - Enrolled Bill communicated to Governor on March 27, 2024
|
Senate Committee Actions:
2/29/2024 - Reported from Finance and Appropriations (14-Y 0-N) 3/4/2024 - Constitutional reading dispensed (40-Y 0-N) 3/5/2024 - Read third time 3/5/2024 - Passed Senate (40-Y 0-N) 3/25/2024 - Signed by President
|
Related Bills:
SB392 (Pekarsky) - Hospitals; emergency departments to have at least one licensed physician on duty at all times.
|
Health
|
Subcommittee recommends reporting with amendments (8-Y 0-N)
|
HB781
|
Herring |
Maternal Health Data and Quality Measures, Task Force on; State Health Commissioner to reestablish. |
Summary:
Task Force on Maternal Health Data and Quality Measures; report.
Directs the State Health Commissioner to reestablish the Task Force on Maternal Health Data and Quality Measures for the purpose of evaluating maternal health data collection processes to guide policies in the Commonwealth to improve maternal care, quality, and outcomes for all birthing people in the Commonwealth. The bill directs the Task Force to report its findings and conclusions to the Governor and General Assembly by December 1 of each year regarding its activities. The bill directs the Task Force to conclude its work by December 1, 2025. This bill reestablishes the Task Force on Maternal Health Data and Quality Measures that concluded on December 1, 2023. The bill incorporates HB 169.
|
Fiscal Impact
|
Last Five Actions:
4/8/2024 - Governor's recommendation received by House 4/8/2024 - Governor's substitute printed 24109298D-H2 4/17/2024 - House rejected Governor's recommendation (25-Y 74-N) 4/17/2024 - VOTE: REJECTED (25-Y 74-N) 4/17/2024 - Communicated to Governor
|
Senate Committee Actions:
2/26/2024 - Reading of amendment waived 2/26/2024 - Committee amendment agreed to 2/26/2024 - Engrossed by Senate as amended 2/26/2024 - Passed Senate with amendment (21-Y 18-N) 3/7/2024 - Signed by President
|
Health
|
Subcommittee recommends reporting with substitute (8-Y 0-N)
|
HB820
|
Mundon King |
Sickle cell disease; annual review of medication and treatment, report. |
Summary:
Department of Medical Assistance Services; annual review of medication and treatment for sickle cell disease; report.
Directs the Department of Medical Assistance Services to conduct an annual review of all medications and forms of treatment for sickle cell disease, and services for enrollees with a diagnosis of sickle cell disease, that are eligible for coverage under the state plan for medical assistance services. The bill requires the Department to report its findings and recommendations by November 15 each year to the Chairmen of the House Committee on Health and Human Services and the Senate Committee on Education and Health and to the Joint Commission on Health Care.
|
Fiscal Impact
|
Last Five Actions:
2/29/2024 - Enrolled 2/29/2024 - Bill text as passed House and Senate (HB820ER) 2/29/2024 - Impact statement from DPB (HB820ER) 2/29/2024 - Signed by Speaker 3/11/2024 - Enrolled Bill communicated to Governor on March 11, 2024
|
Senate Committee Actions:
2/22/2024 - Reported from Education and Health (15-Y 0-N) 2/23/2024 - Constitutional reading dispensed (38-Y 0-N) 2/26/2024 - Read third time 2/26/2024 - Passed Senate (40-Y 0-N) 3/3/2024 - Signed by President
|
Health
|
Subcommittee recommends reporting with amendments (8-Y 0-N)
|